These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15631868)

  • 21. Calcium inhibits human placental 11beta-hydroxysteroid dehydrogenase type 2 activity.
    Hardy DB; Dixon SJ; Narayanan N; Yang K
    Biochem Biophys Res Commun; 2001 May; 283(4):756-61. PubMed ID: 11350048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation.
    Rabbitt EH; Lavery GG; Walker EA; Cooper MS; Stewart PM; Hewison M
    FASEB J; 2002 Jan; 16(1):36-44. PubMed ID: 11772934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N; Stewart PM
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
    Kim CH; Cho YS
    Cell Biochem Funct; 2010 Aug; 28(6):440-7. PubMed ID: 20629036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
    Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
    Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentanol derivatives from basidiomycete Catathelasma imperiale and their 11beta-hydroxysteroid dehydrogenases inhibitory activity.
    Zhang L; Shen Y; Zhu HJ; Wang F; Leng Y; Liu JK
    J Antibiot (Tokyo); 2009 May; 62(5):239-42. PubMed ID: 19329984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid.
    Classen-Houben D; Schuster D; Da Cunha T; Odermatt A; Wolber G; Jordis U; Kueenburg B
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):248-52. PubMed ID: 19429429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.
    Struwe E; Berzl GM; Schild RL; Beckmann MW; Dörr HG; Rascher W; Dötsch J
    Am J Obstet Gynecol; 2007 Jul; 197(1):43.e1-6. PubMed ID: 17618751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
    Gong R; Morris DJ; Brem AS
    Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
    Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
    Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
    Webster SP; Ward P; Binnie M; Craigie E; McConnell KM; Sooy K; Vinter A; Seckl JR; Walker BR
    Bioorg Med Chem Lett; 2007 May; 17(10):2838-43. PubMed ID: 17350260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP; Ebert B; Martin HJ; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
    Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.